KIMMTRI

tebentafusp · Immunocore

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KIMMTRI, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Adjuvant Tebentafusp in High Risk Ocular Melanoma [Phase 3]